Always review the product label for the most current ingredient, allergen, and dietary information before use.
For active, high-output lifestyles
NICE guidance including Technology Appraisal TA875 (semaglutide 2.4 mg for managing overweight and obesity), Clinical Guideline CG189 (Obesity: identification, assessment and management), and Public Health Guidance PH53 (Weight management: lifestyle services for overweight or obese adults) recommends a structured, tiered approach to weight management
If you're 18 or older with a BMI of 30 or more, or 27 and higher with weight-related conditions like type 2 diabetes, you might qualify for oral Wegovy for obesity
The transformation goes beyond body size
If the side effects are too intense, the patient may need to continue taking the lower dosage for longer or may need to consider switching to a different medication or other weight loss alternatives